Patents by Inventor AeRyon KIM

AeRyon KIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240150481
    Abstract: The present invention relates to a human agonistic CD40 multispecific antibody construct for treatment of solid tumors by engineering a molecule that specifically targets the CD40 pathway on tumor-associated APCs, without systemic CD40 activation.
    Type: Application
    Filed: January 19, 2024
    Publication date: May 9, 2024
    Inventors: Xin YU, Jackson EGEN, Fernando GARCES, Shunsuke TAKENAKA, AeRyon KIM, Deepali SAWANT
  • Patent number: 11926672
    Abstract: The present invention relates to a human agonistic CD40 multispecific antibody construct for treatment of solid tumors by engineering a molecule that specifically targets the CD40 pathway on tumor-associated APCs, without systemic CD40 activation.
    Type: Grant
    Filed: December 18, 2020
    Date of Patent: March 12, 2024
    Assignee: Amgen Inc.
    Inventors: Xin Yu, Jackson Egen, Fernando Garces, Shunsuke Takenaka, AeRyon Kim, Deepali Sawant
  • Publication number: 20210347905
    Abstract: The present invention relates to a human agonistic CD40 multispecific antibody construct for treatment of solid tumors by engineering a molecule that specifically targets the CD40 pathway on tumor-associated APCs, without systemic CD40 activation.
    Type: Application
    Filed: December 18, 2020
    Publication date: November 11, 2021
    Inventors: Xin YU, Jackson EGEN, Fernando GARCES, Shunsuke TAKENAKA, AeRyon KIM, Deepali SAWANT